NasdaqGS:NEOGMedical Equipment
Neogen (NEOG) Q3 Losses Keep Margin Concerns Central To Bullish Discount Narrative
Neogen (NEOG) has just posted Q3 2026 results with revenue of US$211.2 million and a basic EPS loss of US$0.08, alongside trailing twelve month revenue of US$870.6 million and a basic EPS loss of US$2.80. This keeps the focus firmly on how efficiently the business is converting sales into earnings. Over recent quarters the company has seen revenue move from US$231.3 million in Q2 2025 to US$225.5 million in Q4 2025, then to US$209.2 million in Q1 2026 and US$224.7 million in Q2 2026 before...